Why is Granules India Ltd ?
- NET SALES(Q) Highest at Rs 1,470.61 cr
- OPERATING PROFIT TO INTEREST(Q) Highest at 10.77 times
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 949.06 cr
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.29% over the previous quarter.
- Along with generating 70.50% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
How much should you buy?
- Overall Portfolio exposure to Granules India should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Granules India for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at Rs 1,470.61 cr
Highest at 10.77 times
Highest at Rs 949.06 cr
Lowest at 0.30 times
Highest at Rs 352.11 cr.
Highest at 23.94%
Highest at Rs 237.67 cr.
Highest at Rs 189.34 cr.
Highest at Rs 8.13
Highest at Rs 32.69 cr
Here's what is working for Granules India
Net Sales (Rs Cr)
Operating Profit to Interest
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
PAT (Rs Cr)
EPS (Rs)
Cash and Cash Equivalents
Debt-Equity Ratio
Here's what is not working for Granules India
Interest Paid (Rs cr)






